Teleflex Incorporated $TFX Shares Sold by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System trimmed its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 5.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,600 shares of the medical technology company’s stock after selling 1,300 shares during the period. Louisiana State Employees Retirement System’s holdings in Teleflex were worth $2,438,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in TFX. Dimensional Fund Advisors LP lifted its stake in shares of Teleflex by 69.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company’s stock valued at $119,927,000 after purchasing an additional 355,720 shares during the period. Diamond Hill Capital Management Inc. lifted its stake in shares of Teleflex by 122.8% in the 1st quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company’s stock valued at $80,784,000 after purchasing an additional 322,222 shares during the period. Invenomic Capital Management LP lifted its stake in shares of Teleflex by 1,400.1% in the 1st quarter. Invenomic Capital Management LP now owns 344,732 shares of the medical technology company’s stock valued at $47,639,000 after purchasing an additional 321,751 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Teleflex by 229.9% in the 1st quarter. Principal Financial Group Inc. now owns 230,522 shares of the medical technology company’s stock valued at $31,856,000 after purchasing an additional 160,646 shares during the period. Finally, Millennium Management LLC lifted its stake in shares of Teleflex by 57.8% in the 1st quarter. Millennium Management LLC now owns 394,633 shares of the medical technology company’s stock valued at $54,534,000 after purchasing an additional 144,531 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

Shares of NYSE TFX opened at $119.54 on Friday. Teleflex Incorporated has a one year low of $108.90 and a one year high of $241.41. The firm has a market cap of $5.28 billion, a PE ratio of 28.13, a PEG ratio of 1.74 and a beta of 1.05. The firm has a fifty day moving average of $124.30 and a 200 day moving average of $124.29. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The business had revenue of $780.90 million during the quarter, compared to analyst estimates of $771.53 million. During the same quarter in the prior year, the firm earned $3.42 earnings per share. The company’s revenue for the quarter was up 4.2% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Friday, August 15th were issued a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.1%. Teleflex’s dividend payout ratio is presently 32.00%.

Insider Buying and Selling at Teleflex

In other Teleflex news, CEO Liam Kelly bought 1,500 shares of the company’s stock in a transaction dated Tuesday, August 5th. The stock was acquired at an average price of $115.07 per share, with a total value of $172,605.00. Following the completion of the acquisition, the chief executive officer directly owned 45,267 shares of the company’s stock, valued at $5,208,873.69. This represents a 3.43% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gretchen R. Haggerty bought 500 shares of the company’s stock in a transaction dated Wednesday, August 6th. The shares were acquired at an average cost of $114.75 per share, with a total value of $57,375.00. Following the acquisition, the director directly owned 6,305 shares of the company’s stock, valued at approximately $723,498.75. This represents a 8.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 5,500 shares of company stock valued at $633,590. 1.40% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on TFX. Mizuho boosted their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a “neutral” rating in a research note on Friday, August 1st. Weiss Ratings reiterated a “sell (d+)” rating on shares of Teleflex in a research note on Wednesday. Zacks Research lowered shares of Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Royal Bank Of Canada boosted their price target on shares of Teleflex from $130.00 to $135.00 and gave the stock a “sector perform” rating in a report on Friday, August 1st. Finally, Wall Street Zen lowered shares of Teleflex from a “strong-buy” rating to a “buy” rating in a report on Monday, September 15th. One research analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average price target of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.